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Abstract
Soluble fermentable dietary fibre elicits gut adaptations, increases satiety and potentially of-
fers a natural sustainable means of body weight regulation. Here we aimed to quantify phys-
iological responses to graded intakes of a specific dietary fibre (pectin) in an animal model.
Four isocaloric semi-purified diets containing 0, 3.3%, 6.7% or 10% w/w apple pectin were
offered ad libitum for 8 or 28 days to young adult male rats (n = 8/group). Measurements
were made of voluntary food intake, body weight, initial and final body composition by mag-
netic resonance imaging, final gut regional weights and histology, and final plasma satiety
hormone concentrations. In both 8- and 28-day cohorts, dietary pectin inclusion rate was
negatively correlated with food intake, body weight gain and the change in body fat mass,
with no effect on lean mass gain. In both cohorts, pectin had no effect on stomach weight
but pectin inclusion rate was positively correlated with weights and lengths of small intestine
and caecum, jejunum villus height and crypt depth, ileum crypt depth, and plasma total glu-
cagon-like peptide-1 (GLP-1) and peptide tyrosine tyrosine (PYY) concentrations, and at 8
days was correlated with weight and length of colon and with caecal mucosal depth. There-
fore, the gut’s morphological and endocrine adaptations were dose-dependent, occurred
within 8 days and were largely sustained for 28 days during continued dietary intervention.
Increasing amounts of the soluble fermentable fibre pectin in the diet proportionately de-
creased food intake, body weight gain and body fat content, associated with proportionately
increased satiety hormones GLP-1 and PYY and intestinal hypertrophy, supporting a role
for soluble dietary fibre-induced satiety in healthy body weight regulation.
Introduction
In the battle to prevent overweight and obesity, satiety-inducing food ingredients such as dietary
fibre offer a natural dietary strategy for caloric intake control and body weight regulation [1]. We
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have recently used an animal model to demonstrate significant reductions in voluntary food in-
take, body weight gain and adiposity when young adult rats were fed diets containing a range of
different soluble fermentable dietary fibres, including pectin [2]. The results indicated that the
presence of soluble fibre was more critical than its source, and this follow-on study addressed the
potential importance of the amount of soluble fibre consumed. Pectin was the highly fermentable
soluble dietary fibre used herein; it is a plant cell structural heteropolysaccharide, naturally occur-
ring in fruit and vegetables, but also commercially extracted, available as a food supplement and
widely used by the food industry [3]. In our earlier rat study, 10% w/w dietary pectin for 4 weeks
increased satiety, decreased food intake, decreased body weight gain and led to loss of body fat
[2]. Since this dietary inclusion rate equated to approximately twice the dietary fibre RDA for
American men [4, 5], lower inclusion rates were included in the present study.
Increased soluble dietary fibre consumption increases circulating concentrations of the gut
satiety hormones glucagon-like peptide-1 (GLP-1) and peptide tyrosine tyrosine (PYY) in rats
[2, 6–8]. There is some evidence to indicate that appetite and food intake suppression by these
peripheral hormones is dose-sensitive [9–11] but it is less clear whether the stimulation of
these hormones by soluble dietary fibre is also dose-sensitive. In support, gene expression for
PYY and GLP-1 was dose-dependently increased in rats given dietary prebiotics [12]. However,
whilst dietary oligofructose dose-dependently increased circulating PYY in a human study, it
did not significantly affect GLP-1, appetite ratings or caloric intake [13]. After 4 weeks of in-
creased soluble dietary fibre in our rat model, the increased circulating concentrations of total
GLP-1 and PYY both correlated with the decreased food intake [2]. Here we sought to deter-
mine the dose dependent effects of the soluble fibre pectin on both circulating satiety hormone
concentrations and food intake.
It has long been noted that rats fed increased amounts of dietary fibre, including pectin,
show increased gut weights and increased intestinal mucosal cell proliferation [14–16] and
more recently the ingestion of prebiotic fibres has been associated with increased gut weight
and length [12]. Increased gut size was observed (but not measured) previously in our model
[2]. Since changes to gut morphometry may ultimately influence the efficacy, safety and accep-
tance of high soluble fibre diets for human body weight control, it is important to examine this
phenomenon more closely. Here we aimed for the first time to quantify this response by weigh-
ing and measuring gut regions after different doses of increased dietary fibre and to character-
ise the response by taking histological measurements of regional mucosal depth.
It is axiomatic that the mammalian gut needs time to adapt to changes in diet composition.
After the abrupt introduction of soluble fibre to the daily diet in our rat model, there followed a
period of adaptation lasting approximately a week before voluntary food intake stabilised at a
steady level for the next 3 weeks [2]. Here we sought to examine whether changes in gut mor-
phometry and/or endocrinology occurred during this adaptation period and so we examined
responses in the short term (~1 week) in addition to the longer term (4 weeks).
Therefore, the purpose of the present study was to examine the dose dependent effects of a
soluble fermentable dietary fibre (pectin) on food intake, body weight and body composition in
young adult male rats. Additional outcome measures following either 8 or 28 days of pectin
consumption included plasma concentrations of satiety hormones, PYY and GLP-1, and char-
acterisation of the changes in gut morphology and histology.
Materials and Methods
Ethics statement
All animal experimental procedures met institutional and national guidelines for the care and
use of animals. They were licensed by the UK Home Office Animals (Scientific Procedures)
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Act, Amended 2012, under Project License 60/4282 and were approved by the local ethical re-
view committee at the University of Aberdeen Rowett Institute of Nutrition & Health (approval
number SA12/04E). The rats were euthanised by decapitation under general inhalation anaes-
thesia (isoflurane; IsoFlo, Abbott Animal Health, Maidenhead, Berkshire, UK).
Diets
All diets were based on the purified AIN-93M diet (American Society for Nutrition, Bethesda,
MD, USA) for the maintenance of adult rats and were made and supplied by Special Diet Ser-
vices Ltd, Witham, Essex, UK. The isocaloric experimental diets (15.7 MJ/kg, calculated from
the standard energy values for carbohydrate, protein, fat and fibre of 16.7, 16.7, 37.6 and 8.4
MJ/kg respectively) contained 3.3%, 6.7% or 10% w/w soluble pectin fibre (apple pectin; Solgar
Apple Pectin, Revital Ltd., Ruislip, Middlesex UK) (3%P, 7%P and 10%P groups, respectively)
while the control diet (C) contained 0% pectin (Table 1). The insoluble dietary fibre cellulose
was included in the C diet and for balancing total fibre in the experimental diets as
appropriate.
Animals, experimental procedure and tissue collection
After 1 week acclimatisation to individual housing in plastic cages while on C diet, 64 outbred
male Sprague Dawley rats (12 weeks old, 444.5 ± 3.70 g; from Charles River Laboratories UK)
were offered the pelleted experimental diets ad libitum for either 8 days or 28 days (n = 8/
group). Water was available ad libitum, the lighting regime was a standard 12 h light and 12 h
dark, temperature was constant at 21±2°C and the relative humidity was held at 55±10%; cages
contained sawdust bedding with shredded paper for nesting and plastic tunnels for further en-
vironmental enrichment. Voluntary food intake was measured daily by weighing uneaten food
each morning and body weight was measured twice a week. Body composition was measured
in conscious rats at the start (day 0) and end (8 days or 28 days) of the experiment by magnetic
resonance imaging (MRI; EchoMRI 2004, Echo Medical Systems, Houston, TX, USA), which
provided total body fat and lean mass data.
Table 1. Composition of experimental diets (%w/w).
Diet
CONT 3%P 7%P 10%P
Maize starch 46.57 41.57 41.57 41.57
Maltodextrin 15.5 15.5 15.5 15.5
Sucrose 10 10 10 10
Casein 14 14 14 14
Soyabean oil 4 4 4 4
AIN-93 Mineral mix 3.5 3.5 3.5 3.5
AIN-93 Vitamin mix 1 1 1 1
Choline bitartrate 0.25 0.25 0.25 0.25
L-cystine 0.18 0.18 0.18 0.18
Cellulose 5 6.7 3.3 0
Pectin1 0 3.3 6.7 10.0
All diets are based on AIN-93M diet (American Society for Nutrition, Bethesda, MD USA).
1 Apple pectin (Solgar Apple Pectin; Revital Ltd., Ruislip, Middlesex UK).
doi:10.1371/journal.pone.0115438.t001
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After the final MRI scan, rats in both 8-day and 28-day cohorts were euthanised approxi-
mately 1–3 h after lights on. Final (trunk) blood samples were collected into chilled tubes con-
taining EDTA as anti-coagulant and a peptidase inhibitor cocktail containing general protease
inhibitor (cØmplete; Roche Diagnostics Ltd, Burgess Hill, West Sussex, UK) and dipeptidyl
peptidase-4 inhibitor (Ile-Pro-Ile; Sigma-Aldrich, Gillingham, Dorset, UK), centrifuged imme-
diately at 3000g for 10 min, then plasma stored at -20oC until analysis. The gut was dissected
out, wet weights were recorded immediately for whole gut, stomach, small intestine, caecum
and colon, and the lengths of small intestine, caecum and colon were measured. Tissue samples
from jejunum, distal ileum, caecum and proximal and distal colon were frozen on dry ice in
Tissue-Tek (O.C.T. Compound, Sakura Finetek UK Ltd., Thatcham, Berkshire, UK) and stored
at -80°C.
Gut histology
Cross sectional cryostat sections (20 µm) of jejunum, distal ileum, caecum, proximal and distal
colon were mounted on microscope slides and stained with haemotoxylin and eosin using stan-
dard methodology (reagents from Sigma-Aldrich). Measurements were taken of villus height
and crypt depth in the jejunum and ileum, and overall depth of mucosa in the caecum, proxi-
mal and distal colon, using Image Pro-plus software (Media Cybernetics Inc., Rockville, MD,
USA) linked to a light microscope (Leica DMR; Leica Microsystems (UK) Ltd., Milton Keynes,
UK). Up to 10 measurements were taken at 5x magnification in vertical cross sectional plane at
different sites from 2 sections per gut region per rat in order to provide an average value for
each parameter for each individual.
Plasma analyses
Plasma samples were analysed by commercial RIA kits according to the manufacturers’ in-
structions. Total GLP-1 was measured by kit GLP1T-36HK (Merck Millipore, Billerica, MA,
USA; lower detection limit 3 pM) which detects all forms of GLP-1. Active GLP-1 was not mea-
sured because it has a short half-life in plasma, and measurement of total GLP-1 provides an
accurate indication of overall GLP-1 secretion since it includes both the intact hormone and its
primary metabolite [17]. PYY was measured by kit RMPYY-68HK (Merck Millipore; lower de-
tection limit 15.6 pg/ml), which detects both of the circulating biologically active forms of PYY,
namely PYY(1–36) and PYY(3–36).
Statistical methods
Daily food intakes and twice weekly body weight data were analysed within 8-day and 28-day
cohorts by repeated measures ANOVA (General Linear Model (GLM) with time, diet and their
interaction as factors; Minitab Version 16, Minitab Inc., State College, PA). Group compari-
sons for all other data were performed by ANOVA (one-way or GLM with cohort, diet and
their interaction as factors as appropriate) followed by Tukey’s post-hoc tests, and Pearson’s
product-moment correlation was used to examine relationships between measured parameters
where indicated (Minitab). P values of 0.05 or less were considered statistically significant.
Results
Food intake, body weight and body composition
Daily food intake diverged immediately between the diet groups (Fig. 1a,b). Repeated measures
ANOVA revealed significant effects of diet (P<0.001) and time (P<0.001) for both cohorts,
with a significant diet x time interaction (P<0.001) only for the 28-day cohort. Daily intakes
Dose-Dependent Effects of Soluble Dietary Fibre
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were significantly different between all four groups in the 8-day cohort, C> 3%P> 7%P>
10%P, and were C = 3%P> 7%P> 10%P in the 28-day cohort (Fig. 1a,b). Importantly, repeat-
ed measures ANOVA from day 14 onwards for the 28-day cohort (i.e. excluding the early peri-
od of very low intakes) revealed similarly significant effects of diet on daily food intake (C = 3%
P>7%P>10%P; P<0.001). Compared with respective C groups, cumulative intake by the 8-
day cohort was decreased in 3%P (P<0.01), 7%P (P<0.001) and 10%P (P<0.001) groups and
by the 28-day cohort was decreased in 7%P (P<0.01) and 10%P (P<0.001) groups (Fig. 1c,d).
Overall, cumulative intake in both cohorts showed highly significant negative correlation with
the amount of pectin in the diet (both P<0.001; Fig. 1e,f).
Repeated measures ANOVA revealed significant effects of diet (P<0.002) and time
(P<0.001) on twice-weekly body weights for the 28-day cohort but no effects for the 8-day co-
hort (Fig. 2a,b). However, compared with their respective C groups, overall body weight gain
was decreased in 3%P (P<0.01), 7%P (P<0.01) and 10%P (P<0.001) groups in the 8-day co-
hort and in 3%P (P<0.01), 7%P (P<0.01) and 10%P (P<0.001) groups in the 28-day cohort
(Fig. 2c,d); and body weight gain correlated negatively with the amount of pectin in the diet in
both cohorts (r = -0.688 and -0.752, respectively, both P<0.001). Total lean tissue gain was not
different between the groups in either cohort (Fig. 3a,b). In the 8-day cohort, total body fat
mass increased in group C, showed no change in 3%P (P<0.01 compared with C) but
Figure 1. Food intake. Daily (a, b) and cumulative (c, d) voluntary food intake by rats offered control diet
(C) or diet containing 3, 7 or 10% pectin (P) for 8 days (a, c) or 28 days (b, d), and correlation between
cumulative intake and amount of P in the diet in 8-day (e) and 28-day (f) cohorts. Results of repeated
measures ANOVA are indicated in figures a and b. Columns labelled with different letters in figures c and d
are significantly different by one-way ANOVA, P<0.05, and r is the Pearson product-moment correlation
coefficient in figs e and f, ***P<0.001.
doi:10.1371/journal.pone.0115438.g001
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decreased in 7%P and 10%P groups (both P<0.001 compared with C; Fig. 3c). In the 28-day
cohort, total fat mass increased in group C, showed a smaller increase in 3%P (P<0.01 com-
pared with C), no change in 7%P (P<0.001) and a decrease in the 10%P group (P<0.001;
Fig. 3d). In both cohorts the increase in total body fat mass correlated negatively with the
amount of pectin in the diet (both P<0.001; Fig. 3e,f). Final total body lean tissue percentage
was higher in 7%P and 10%P groups than group C in the 8-day cohort (P<0.01) but was not
different between groups in the 28-day cohort (Fig. 3g,h). Final total body fat percentage was
lower in 10%P (P<0.01) than group C in the 8-day cohort and lower in 7%P and 10%P (both
P<0.001) than group C in the 28-day cohort (Fig. 3i,j).
Gut morphology
Overall weights of whole gut (9%, P<0.01) and caecum (24%, P<0.001) and length of small in-
testine (4%, P<0.01) were greater in the 28-day rats than in the 8-day cohort, but weights of
stomach, small intestine and colon and lengths of caecum and colon were not different; there
were no cohort x diet interactions and the data are presented separately for each cohort in
Table 2. Compared with their respective C groups, whole gut weight was greater in 7%P
(P<0.01) and 10%P (P<0.001) groups in the 8-day cohort and in the 10%P group in the 28-
day cohort (P<0.01); within each cohort whole gut weight correlated significantly with the
amount of pectin in the diet (both P<0.001; Table 2). Stomach weight was not different be-
tween the groups in either cohort. Compared with their respective C groups, small intestine
weight was greater in 3%P (P<0.01), 7%P and 10%P groups (both P<0.001) in the 8-day co-
hort and the 7%P and 10%P groups in the 28-day cohort (both P<0.001); within each cohort
small intestine weight correlated significantly with the amount of pectin in the diet (both
P<0.001; Table 2). Similarly, in both 8-day and 28-day cohorts, small intestine length was in-
creased in 7%P (P<0.05 and P<0.01, respectively) and 10%P groups (P<0.01 and P<0.001, re-
spectively) and correlated significantly with the amount of pectin in the diet (both P<0.001;
Table 2). Caecum weight was greater in 3%P (P<0.01), 7%P (P<0.001) and 10%P groups
(P<0.001) than the C group within each cohort and correlated significantly with the amount of
Figure 2. Body weight.Changes in body weight in rats offered control diet (C) or diet containing 3, 7 or 10%
pectin (P) for 8 days (a, c) or 28 days (b, d). Results of repeated measures ANOVA are indicated in fig b.
Within figures c and d, columns labelled with different letters are significantly different by one-way ANOVA,
P<0.05.
doi:10.1371/journal.pone.0115438.g002
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pectin in the diet (both P<0.001; Table 2). Similarly caecum length was greater in 3%P
(P<0.01), 7%P (P<0.001) and 10%P groups (P<0.001) within each cohort and correlated sig-
nificantly with the amount of pectin in the diet (both P<0.001; Table 2). In the 8-day cohort,
colon weight was greater in 7%P and 10%P groups than the C group (both P<0.01) and corre-
lated significantly with the amount of pectin in the diet (P<0.001); in the 28-day cohort, colon
weight was greater in 3%P and 7%P groups than the C group (both P<0.01) and did not corre-
late with the amount of pectin in the diet (Table 2). In the 8-day cohort, colon length was great-
er in the 10%P group than C (P<0.01) and correlated with the amount of pectin in the diet
(P<0.001), while in the 28-day cohort there were no group differences in colon length and no
correlation (Table 2).
Figure 3. Body composition (by MRI).Changes in total lean tissue mass (a, b) and total fat mass (c, d),
correlation between change in body fat mass and amount of pectin in the diet (e, f), final total body lean tissue
percentage (g, h), and final total body fat percentage (i, j) in rats offered control diet (C) or diet containing 3, 7
or 10% pectin (P) for 8 days (a, c, e, g, i) or 28 days (b, d, f, h, j). Within figures, columns labelled with different
letters are significantly different by one-way ANOVA, P<0.05, and r is the Pearson product-moment
correlation coefficient, ***P<0.001.
doi:10.1371/journal.pone.0115438.g003
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Gut histology
Overall, gut histology measurements were not significantly different between the cohorts ex-
cept for mucosal depth in the proximal colon which was greater in 28-day than 8-day rats
(14%, P<0.01). However, there were overall significant effects of pectin-containing diets in-
creasing mucosal depth in the caecum (P<0.05) and proximal colon (P<0.05), increasing
crypt depth in the jejunum (P<0.001) and distal ileum (P<0.001) and villus height in the jeju-
num (P<0.01). There were significant cohort x diet interactions for crypt depth in the jejunum
and distal ileum (both P<0.001) since the dietary effect was greater in the 28-day cohort. Data
are presented separately for each cohort in Table 2. Compared with their respective C groups,
in the 8-day cohort ileum crypt depth was significantly greater in the 7%P group (P<0.001)
and caecum mucosa thickness was greater in the 10%P group (P<0.001), while in the 28-day
cohort jejunum and ileum crypt depths were greater in the 10%P group (both P<0.001,
Table 2). Correlation analysis revealed significant positive relationships with the amount of di-
etary pectin in both the 8-day and 28-day cohorts for jejunum villus height (both P<0.05),
Table 2. Gut regional weights, lengths and histological measurements in rats fed control diet (C) or diet containing 3, 7 or 10% pectin (P) for 8
days or 28 days.
8-day cohort diet groups 28-day cohort diet groups
C 3%P 7%P 10%P r C 3%P 7%P 10%P r
Gut morphology
Whole gut weight (g) 27.7a
±1.5
30.6ab
±1.3
34.4bc
±1.1
36.6c ±1.0 0.716*** 30.6a ±1.5 35.0ab
±1.4
35.8ab
±1.2
39.2b ±1.9 0.589***
Stomach weight (g) 6.3 ±0.5 5.4 ±0.4 6.5 ±0.7 5.2 ±0.3 -0.153 4.8 ±0.8 6.0 ±0.8 6.1 ±0.7 5.8 ±0.7 0.168
Small intestine weight
(g)
8.4a ±0.4 10.0b ±0.4 11.6c ±0.3 13.8d ±0.3 0.910*** 9.3a ±0.4 10.5ab
±0.3
11.6b ±0.4 13.3c ±0.5 0.808***
Small intestine length
(mm)
1043a
±14
1057ab
±13
1123bc
±21
1149c ±29 0.617*** 1086a ±11 1105ab
±13
1154bc
±19
1184c ±16 0.688***
Caecum weight (g) 3.0a ±0.2 4.7b ±0.2 5.4b ±0.4 7.0c ±0.5 0.834*** 3.5a ±0.2 5.4b ±0.3 6.8b ±0.5 9.3c ±0.6 0.876***
Caecum length (mm) 37.5a
±0.9
44.1b ±1.9 50.6c ±1.7 56.9d ±1.3 0.874*** 35.9a ±1.1 44.4b ±1.5 52.8c ±1.9 59.4d ±1.7 0.902***
Colon weight (g) 2.4a ±0.2 3.6ab ±0.3 4.1b ±0.5 4.4b ±0.4 0.560*** 2.3a ±0.3 4.2b ±0.3 3.9b ±0.5 3.5ab ±0.4 0.297
Colon length (mm) 157a ±4 176ab ±7 183ab ±9 194b ±8 0.561*** 166 ±5 171 ±2 174 ±4 174 ±6 0.157
Gut histology (µm)
Jejunum villus height 583.5
±47.2
612.3
±15.2
647.0
±21.1
685.9
±18.9
0.499* 539.9
±25.5
630.7
±40.1
661.2
±39.9
672.1
±63.7
0.483*
Jejunum crypt depth 172.1
±17.0
159.7 ±6.1 195.4
±17.5
216.2
±16.4
0.440* 149.2a
±9.5
158.5a
±8.6
183.8a
±16.2
292.5b
±16.8
0.815***
Distal ileum villus
height
263.5
±20.7
335.8
±34.3
382.4
±48.8
311.6
±25.0
0.173 295.9
±11.8
315.9
±23.3
281.3 ±6.5 338.7
±20.6
0.205
Distal ileum crypt
depth
150.0a
±8.2
158.5a
±11.2
213.8b
±13.4
179.8ab
±13.6
0.491* 150.7a
±12.7
153.3a
±16.1
172.7a
±12.4
263.4b
±27.4
0.662***
Caecum mucosa
depth
184.3a
±8.3
188.6a
±7.7
209.6ab
±7.6
231.8b ±7.2 0.681*** 209.5
±15.1
206.4 ±7.9 217.8
±12.4
215.8 ±8.2 0.115
Proximal colon
mucosa depth
151.7
±8.4
193.6
±17.1
176.2 ±9.7 188.8
±13.7
0.241 178.7
±12.7
209.8
±19.5
210.1
±10.0
210.2 ±9.3 0.308
Distal colon mucosa
depth
215.7
±6.0
221.8
±21.5
236.2
±21.2
230.4
±14.9
0.195 224.8 ±6.9 238.0
±11.8
252.2
±16.1
251.1
±11.0
0.340
Values are means ± s.e.m. (n = 8/group). Within rows and cohorts, means with different superscript letters are signiﬁcantly different, P<0.05. r, correlation
with %P (Pearson correlation coefﬁcient; n = 32/cohort);*** P<0.001, * P<0.05.
doi:10.1371/journal.pone.0115438.t002
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jejunum crypt depth (P<0.05 and P<0.001, respectively) and distal ileum crypt depth (P<0.05
and P<0.001, respectively) and in the 8-day cohort only for caecum mucosal depth (P<0.001;
Table 2).
Plasma satiety hormone concentrations
There was no difference between the cohorts for plasma PYY concentrations, but significant ef-
fects of diet. Compared with respective C groups, plasma PYY concentrations were increased
in 7%P and 10%P groups in the 8-day cohort (both P<0.001; Fig. 4a) and in 3%P, 7%P and
10%P groups in the 28-day cohort (P<0.05–0.001; Fig. 4c). In the 8-day cohort, plasma PYY
correlated with the amount of pectin in the diet (P<0.001; Fig. 4b) and with the weights of
small intestine (r = 0.794, P<0.001), caecum (r = 0.721, P<0.001) and colon (r = 0.444,
P<0.01), and correlated negatively with cumulative food intake (r = -0.745, P<0.001). Similar-
ly, in the 28-day cohort, plasma PYY correlated with the amount of pectin in the diet
(P<0.001; Fig. 4d) and with the weights of small intestine (r = 0.720, P<0.001) and caecum
(r = 0.723, P<0.001), but not colon (r = 0.240), and correlated negatively with cumulative food
intake (r = -0.451, P<0.01).
Figure 4. Satiety hormones. Plasma concentrations of PYY (a, c) and total GLP-1 (e, g) in rats offered
control diet (C) or diet containing 3, 7 or 10% pectin (P) for 8 days (a, e) or 28 days (c, g); and correlations
between amount of pectin in the diet and PYY and total GLP-1 concentrations in the 8-day (b, f) and 28-day
(d, h) cohorts. Within figures, columns labelled with different letters are significantly different by one-way
ANOVA, P<0.05, and r is the Pearson product-moment correlation coefficient, ***P<0.001.
doi:10.1371/journal.pone.0115438.g004
Dose-Dependent Effects of Soluble Dietary Fibre
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There were effects of cohort (8-day>28-day, P<0.01) and diet (P<0.001) and cohort x diet
interaction (P<0.001) for plasma total GLP-1 concentrations. Compared with respective
C groups, plasma total GLP-1 concentrations were increased in 7%P and 10%P groups in the
8-day cohort (both P<0.001; Fig. 4e) and in the 10%P group in the 28-day cohort (P<0.001;
Fig. 4g). In both the 8-day and 28-day cohorts, plasma total GLP-1 correlated with the amount
of pectin in the diet (both P<0.001; Fig. 4f,h) and with the weights of small intestine (r = 0.583
and 0.575, respectively; both P<0.001) and caecum (r = 0.596 and 0.674, respectively;
P<0.001), but not colon (r = 0.193 and 0.000, respectively). Plasma total GLP-1 correlated neg-
atively with cumulative food intake in both the 8-day and 28-day cohorts (r = -0.585 and
-0.541, respectively; P<0.001) and positively with plasma PYY concentrations (r = 0.816 and
0.681, respectively; both P<0.001).
Discussion
This study has demonstrated in an animal model that increasing amounts of the soluble fibre
pectin in the diet proportionately decreased food intake, body weight gain and body fat con-
tent, and proportionately increased gut size and circulating PYY and total GLP-1 concentra-
tions, in both the short- and long-term. The data are consistent with PYY and GLP-1 being
involved in mediating dietary fibre-induced satiety and demonstrate how the gut’s morpholog-
ical and endocrine adaptations are dose-sensitive, occur within 8 days and are sustained over at
least 28 days during continued dietary intervention.
The present results agree with the dose-dependently decreased caloric intake reported in
rats given up to 20% dietary inulin:oligofructose for 10 weeks [12] although increasing doses of
a mixed cocktail of soluble dietary fibres were found to have no effect on food intake 3 h later
in humans [18], the difference most likely being attributable to the very short-term design of
the latter study. Importantly, the reductions in food intake herein were accompanied by signifi-
cant decreases in body weight gain and specifically prevented fat mass gain whilst maintaining
normal lean tissue gain.
At 12 weeks of age the present rats were young adults, having ceased the juvenile rapid
growth phase but nonetheless continuing to gain body mass at a slower rate [19]. This rate of
gain was decreased throughout the 28-day experiment in inverse proportion to the amount of
soluble fibre in the diet. Although the immediate response was likely due to the abrupt decline
in food intake upon introduction of pectin to the experimental diets, the effect was nonetheless
sustained. Importantly, after both 8 and 28 days, there was no effect of soluble dietary fibre on
lean tissue gain and the differences in body weight gain were entirely attributable to a dose-
dependent inhibition of body fat gain. This indicates that soluble dietary fibre may be particu-
larly suitable for healthy body weight regulation in humans. Here the greatest reductions in
body weight and body fat gain occurred at the highest dose of 10% pectin w/w, or approximate-
ly 6.6mg/kJ, but were nonetheless significant (by extrapolation) at 5% w/w, or 3.3 mg/kJ, which
is the recommended daily fibre intake for US men [4, 5]. Thus practicable levels of soluble die-
tary fibre have clear potential to limit weight gain by limiting body fat accumulation whilst
maintaining lean mass, and this approach is worthy of further investigation in humans. In one
human study using dietary pectin (10g) for 15 days satiety ratings were increased in women
but effects on caloric intake were inconsistent and there was no effect on body weight [20];
however this dose rate was low (equivalent to about 1.2 mg/kJ) compared with the present find-
ings and higher doses for humans may reveal more positive results.
The decrease in food intake was interpreted here as a measure of increased satiety since in-
takes correlated with circulating concentrations of satiety hormones PYY and GLP-1, as ob-
served previously in soluble fibre-fed young adult rats [2] but now also seen across different
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fibre doses and time points. In support, peripheral PYY administration dose-dependently in-
hibits food intake in rats [9, 10] and food intake inhibition by peripheral GLP-1 is linearly re-
lated to the dose infused in humans [21]. Pectin consumption dose-dependently increased
tonic secretion of both of these hormones in the present study after both 8 and 28 days, with
PYY showing the closer relationship (Fig. 4). Similarly, dietary inulin:oligofructose for 10
weeks dose-dependently increased the active GLP-1 response to a meal and intestinal mRNA
levels of both proglucagon (GLP-1 precursor) and PYY in rats [12]. These hormones are co-
secreted (reflected here in the close correlation between their plasma concentrations) by enter-
oendocrine L-cells, which are distributed fairly evenly along the rat jejunum, ileum and colon
[22]. The increase in secretory output may be due to increased activity per cell and/or increased
total L-cell number. It is possible that short-chain fatty acids (SCFA) produced from the fibre
fermentation may play a signalling role, since SCFA stimulation of L-cell PYY and GLP-1 se-
cretion has been demonstrated in human and rodent models [23–26]. However, given the
greatly increased dimensions of both small and large intestines, it is also highly likely that the
total L-cell number along the GI tract was increased, as seen in the typical gut hypertrophy fol-
lowing bariatric surgery [27]. In support, there were significant positive correlations seen here
between both PYY and total GLP-1 and weights of small intestine and caecum.
This new rat study corroborates earlier studies in which ingestion of soluble fibre has been
reported to alter the physical characteristics of the gut, notably increasing its weight and length
[12, 16] and stimulating intestinal mucosal cell proliferation [15]. Other rat studies specifically
using dietary pectin also report increased weights of small intestine, caecum and colon, with in-
creased crypt depths and villus heights in jejunum and ileum, and increased intestinal epithelial
cell proliferation [14, 28, 29]. Evidence suggests that these physical changes in gut are stimulat-
ed by the fermentation products of dietary fibre. In rats, increased soluble fibre, including pec-
tin, increases SCFA production in caecum and colon [2, 30]. Caecal and colonic infusions of
SCFAs have been shown to stimulate intestinal mucosal growth and epithelial cell proliferation
in rats [31–33], while the proliferative response of the intestinal epithelium to fermentable die-
tary fibre is abolished in germ-free rats [15].
Although the increases in large intestine size may have been anticipated to accommodate
the increased fermentation processes for the pectin-containing diets, additional dose-
dependent increases in size were observed for the small intestine. Furthermore, the underlying
histological changes (increases in villus height and crypt depth) were most significant in the
small intestine, i.e. upstream of fermentation in the caecum/colon, and were therefore unlikely
to have been caused by local actions of fermentation products in the lumen. Indeed a similar
gut hypertrophy following bariatric surgery occurs without changes in diet composition or
hindgut fermentation. Thus Hansen et al observed hypertrophy of the small intestinal gut mu-
cosa in Roux-en-Y gastric by-pass (RYGB)-operated rats [27] and Borg et al reported hypertro-
phy and increased small intestinal cell proliferation in rats with biliopancreatic diversion
(BPD) [34]. In addition, RYGB rats had a doubling of total number of L-cells, with no change
in their density, and hence an approximate two-fold increase in intestinal expression of PYY
and preproglucagon mRNAs [27], while BPD rats had increased circulating concentrations of
PYY, GLP-1 and GLP-2 [34]. While the increases in these hormones are likely a consequence
of the L-cell proliferation, which is secondary to gut hypertrophy, they may also be involved in
further stimulating the mucosal hypertrophy. GLP-2 is known to potently stimulate intestinal
epithelial proliferation [35, 36] and it is synthesised from the L-cell preproglucagon gene in a
1:1 stoichiometric ratio with GLP-1 [37, 38]. Although GLP-2 was not measured directly in the
present rats in view of its short half-life and the single terminal blood sampling protocol em-
ployed, it is likely that it would have been increased along with the elevated GLP-1 concentra-
tions and could therefore have played an intestinotrophic role in the pectin-fed animals.
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Meanwhile, known actions of PYY also include delaying gastro-intestinal transit and slow-
ing gastric emptying [39], and both PYY and GLP-1 are implicated in activating the so-called
ileal brake [40]. The resulting longer gut transit times would likely further influence overall
rates of digestion and nutrient absorption, with potentially significant alterations in the nutri-
ent milieu to which the intestinal epithelium is exposed along its length. In addition, viscous di-
etary fibres such as pectin may directly slow transit times via gel formation and may also
inhibit absorption of bile acids and minerals [41], thereby further influencing the nutrient pro-
file to which the intestinal epithelium is exposed throughout the gut.
Therefore, significant effects on gut hypertrophy and hyperplasia accompany the desirable
effects of soluble fermentable dietary fibre on reduced food intake, body weight gain and adi-
posity. However, despite the increased weight of the gut, which might be perceived as undesir-
able, significant reductions in overall body weight gain are still observed. Moreover, gross,
microscopic and functional changes in the gut are normal adaptive responses to numerous fac-
tors, most commonly diet, but also for example bariatric surgery. In the latter scenario, the in-
testinal mucosal hypertrophy and crypt cell proliferation are seen as fundamental to the
healthy post-operative outcome and sustained weight loss [27, 34, 42].
In conclusion, this is the first report of the dose-dependency of a range of physiological, in-
testinal and endocrine responses to increased soluble dietary fibre (pectin). It seems from our
animal model that increments in daily fibre intake lead to proportional increases in satiety hor-
mones and decreases in food intake and body weight/fat gain, while proportionately increasing
intestinal size and mucosal hypertrophy/hyperplasia; these effects are manifest within 8 days
and sustained for at least 28 days. It remains to be tested whether similar responses are seen in
humans given similar dietary interventions.
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